| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.14 | 0.6 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |